The Scientist - Home

Fly avatars bearing multiple genetic changes akin to those of a cancer patient lead to a tailor-made treatment that has shrunk the patient’s tumors.

As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.

Blocked resources and the suspension of research scholarships threaten the future of Brazilian science, academics say.

An artificial intelligence program called a neural network exceeds radiologists’ ability to detect malignancies, but more testing is needed before using the program clinically.

A new analysis finds that ice melt in Greenland and Antarctica could lead to increases of 2 meters by the end of the century if carbon emissions are not reduced.

Twenty current and former students claim anthropologist David Yesner sexually harassed them and that the college didn’t take action until years after the complaints started.

The Centers of Cancer Nanotechnology Excellence were established in 2005 through several phases of funding, which are reported to end next year.

More than 1,100 people have died in the current Ebola outbreak in Democratic Republic of Congo that started in August 2018.

In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).

The finding overturns the idea that the insect’s first victims were bats and reveals that certain species started targeting humans as a side snack, not as a main meal.

An experimental hearing aid differentiates speakers and monitors the wearer’s brain activity to amplify the one she is trying to listen to.

Study shows the viability of bacteria with human-made, recoded DNA.